| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.97B | 13.94B | 11.55B | 10.07B | 8.55B | 8.21B |
| Gross Profit | 9.88B | 7.63B | 4.88B | 4.25B | 3.60B | 2.98B |
| EBITDA | 3.92B | 3.66B | 3.10B | 2.18B | 2.18B | 1.77B |
| Net Income | 1.61B | 1.49B | 1.46B | 969.50M | 1.11B | 906.80M |
Balance Sheet | ||||||
| Total Assets | 78.30B | 70.67B | 64.26B | 51.62B | 38.36B | 33.34B |
| Cash, Cash Equivalents and Short-Term Investments | 1.41B | 1.40B | 14.99B | 971.50M | 738.40M | 402.60M |
| Total Debt | 1.14B | 14.00B | 13.49B | 8.32B | 6.42B | 6.59B |
| Total Liabilities | 54.50B | 47.32B | 44.08B | 40.80B | 29.17B | 24.78B |
| Stockholders Equity | 23.77B | 23.32B | 20.15B | 10.78B | 9.14B | 8.51B |
Cash Flow | ||||||
| Free Cash Flow | 1.86B | 1.78B | 2.44B | 1.84B | 1.21B | 1.58B |
| Operating Cash Flow | 2.02B | 1.93B | 2.58B | 2.03B | 1.39B | 1.70B |
| Investing Cash Flow | -15.84B | -15.88B | -1.59B | -3.29B | -1.00B | -3.43B |
| Financing Cash Flow | -112.00M | 1.72B | 13.05B | 2.87B | 212.60M | 2.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $68.59B | 14.27 | 45.09% | 0.82% | 7.51% | 55.21% | |
72 Outperform | $52.31B | 16.94 | 6.91% | 1.01% | 25.34% | -5.29% | |
71 Outperform | $10.34B | 19.44 | 25.03% | 1.90% | 4.80% | -6.97% | |
70 Outperform | $19.47B | 12.74 | 9.35% | 0.77% | 29.22% | -2.51% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $23.99B | 23.29 | 20.98% | 1.14% | 0.92% | ― |